Results 151 to 160 of about 18,516 (170)

Faculty Opinions recommendation of Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins. A molecular link of two tumor suppressor pathways.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2004
openaire   +1 more source

Tuberous Sclerosis Complex Diagnostic Criteria Update: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

Pediatric Neurology, 2013
Harry Chugani, David Franz, Mustafa Şahin   +2 more
exaly  

Epilepsy and Neurodevelopmental Comorbidities in Tuberous Sclerosis Complex: A Natural History Study

Pediatric Neurology, 2020
Michael Frost, Mustafa Şahin, Ajay Gupta   +2 more
exaly  

Folliculocystic and collagen hamartoma of tuberous sclerosis complex

Journal of the American Academy of Dermatology, 2012
Isabel Colmenero, Joan C Ferreres, Antonio Torrelo   +2 more
exaly  

Tuberous sclerosis complex: Recent advances in manifestations and therapy

International Journal of Urology, 2017
Mari Wataya-Kaneda, Norio Nonomura, Kazutoshi Fujita   +2 more
exaly  

Tuberous Sclerosis Complex Surveillance and Management: Recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference

Pediatric Neurology, 2013
Harry Chugani, Mary Kay Koenig, David Franz   +2 more
exaly  

Structure of the Tuberous Sclerosis Complex 2 (TSC2) N Terminus Provides Insight into Complex Assembly and Tuberous Sclerosis Pathogenesis

Journal of Biological Chemistry, 2016
Stephan Kiontke, Uwe Mueller, Andrea Oeckinghaus   +2 more
exaly  

Use of mTOR Inhibitor Everolimus in Three Neonates for Treatment of Tumors Associated With Tuberous Sclerosis Complex

Pediatric Neurology, 2015
Nagib Dahdah, Philippe Major
exaly  

Fetal rhabdomyoma: prenatal diagnosis, clinical outcome, and incidence of associated tuberous sclerosis complex

Journal of Pediatrics, 2003
Lisa Hornberger, Greg Ryan, David Chitayat   +2 more
exaly  

Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex

Drugs in R and D, 2012
Mary Kay Koenig, Joshua Samuels, Hope Northrup   +2 more
exaly